Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Executive Q&A: Joe Panetta, CEO, Biocom

Joe Panetta has served as president and CEO of Biocom since 1999. Biocom is an association for life science companies and service providers.

Tease photo

Co. Cuts Jobs, Sees Stock Plummet Following Weak Results

Brain Cancer Combo Didn’t Outperform Chemo

Tocagen is set to slash its workforce by 65% after its brain cancer therapy flopped in a late-stage clinical trial.

Illumina, PacificBio Extend Acquisition

San Diego Company to Provide Cash Payments in the Meantime

The deadline for Illumina Inc. to acquire Pacific Biosciences has been extended as a U.K. regulator continues to review the $1.2 billion deal.

Leadership Changes At Akcea Therapeutics Include New CEO

Ionis to Deepen Its Commitment to the Company

Akcea Therapeutics on Sept. 23 announced the departures of CEO Paula Soteropoulos, President Sarah Boyce and Chief Operating Officer Jeff Goldberg.

Tease photo

Some Biotech Cos. Find Advantages They Need in S.D.

Talent Pool and Area’s Research Institutions Cited By Cos. Moving

DelMar Pharmaceuticals recently joined a short list of biotechs that moved to the region this year.

Co.’s Antifungal Success May Help Other Efforts

MEDICINE: Drug May Help In Bone Marrow Transplants

Antibiotic-resistant infections grab headlines.

Tease photo

UCSD to Open School of Public Health

EDUCATION: It Will Aim for Greater Collaborative Efforts

UC San Diego has won approval for a school of public health that would connect its efforts in medicine, technology, data science and other fields.

Tease photo

DNA Printer and Tech for Improved Photosynthesis Score Funding Rounds

ZeaKal Raises $15M; SGI-DNA Takes in $25M

Two San Diego biotechs with head-turning technology recently picked up venture funding.

Tease photo

Pursuing ‘Untapped Biology,’ Boundless Bio Receives $46.4 Million

BIOTECH: Company Tackling ecDNA’s Role in Cancer Cells

Boundless Bio Inc. emerged Sept. 19 with $46.4 million in funding and a claim to new territory: extrachromosomal DNA.

Three Executives Out at Akcea Therapeutics

Akcea Therapeutics on Sept. 23 announced the departure of CEO Paula Soteropoulos, president Sarah Boyce and chief operating officer Jeff Goldberg.

More stories >>